Life Extension Product References

Mood Relief

1. CNS Spectr. 2001 Aug;6(8):663-70.
2. Mol Psychiatry. 2007 Apr;12(4):331-59. Epub 2007 Jan 16. Review.
3. Neuropsychopharmacology. 2000 Jan;22(1):52-63.
4. Arch Gen Psychiatry. 1994 Sep;51(9):687-97.
5. Dialogues Clin Neurosci. 2008;10(2):141-52.
6. Z Kinder Jugendpsychiatr Psychother. 2008 Jan;36(1):27-43.
7. Curr Psychiatry Rep. 2008 Apr;10(2):178-89.
8. Mol Psychiatry. 2009 Jan 6. [Epub ahead of print]
9. Stephen Daniells, 22-Mar-2007. Berkem builds science to support anti-stress ingredient. http://www.nutraingredients.com/Research/Berkem-builds-science-to-support-anti-stress-ingredient Accessed Jan, 14 2009
10. Psychosom Med. 2004 Jul-Aug;66(4):607-13
11. Neuropsychopharmacology. 2003 Oct;28(10):1871-81.
12. J Herb Pharmacother. 2006;6(2):21-30.
13. Biochem Biophys Res Commun. 2004 Jul 16;320(1):116-22.
14. Neurotoxicology. 2008 Jul;29(4):656-62.
15. Biol Pharm Bull. 2002 Dec;25(12):1513-8.
16. Lancet Infect Dis. 2003 Oct;3(10):644-52.
17. Nutrition. 2001 Jul-Aug;17(7-8):654-6.
18. Pharmacol Biochem Behav. 2001 Sep;70(1):105-14.
19. Biochim Biophys Acta. 1983 Nov 23;735(3):367-79.
20. Neuroreport. 2001 Dec 21;12(18):3939-42.
21. Drugs. 1994 Aug;48(2):137-52.
22. Acta Neurol Scand Suppl. 1994;154:19-26.
23. Scand J Gastroenterol. 1989 May;24(4):407-15.
24. Dig Dis Sci. 1998 Oct;43(10):2211-22.
25. Minerva Gastroenterol Dietol. 1992 Jul-Sep;38(3):145-51.
26. Am J Clin Nutr. 2002 Nov;76(5):1158S-61S
27. Mech Ageing Dev. 1984 Aug;26(2-3):149-64.
28. Evidence Report/Technology Assessment: Number 64 S-Adenosyl-L-Methionine for Treatment of Depression, Osteoarthritis, and Liver Disease http://www.ahrq.gov/clinic/epcsums/samesum.htm
29. Br J Pharmacol. 1999 Jun;127(3):645-54.
30. Zhonghua Wai Ke Za Zhi. 2002 Jun;40(6):407-10.
31. Kaohsiung J Med Sci. 2001 Sep;17(9):455-60.
32. Am J Clin Nutr. 2002 Nov;76(5):1151S-1157S.
33. Br J Rheumatol. 1997 Jan;36(1):27-31.
34. Rev Clin Esp. 1990 Jun;187(2):74-8.
35. Nippon Noegik Kaishi. 1998; 72:153-57
36. Neurochem Res. 1998 May;23(5):667-73.
37. CNS Drugs. 2003;17:539-562.
38. Schweiz Rundsch Med Prax. 2000 Dec 14;89(50):2111-21.
39. Int J Clin Pharmacol Ther. 1999 Mar;37(3):111-9. Review.
40. Pharmacopsychiatry. 1997 Sep;30 Suppl 2:108-12.
41. Arch Intern Med. 2000 Jan 24;160(2):152-6. Review.
42. Eur Arch Psychiatry Clin Neurosci. 2003 Jun;253(3):140-8.
43. Br J Clin Pharmacol. 2002 Sep;54(3):277-82.